Author Correction: ATR inhibition augments the efficacy of lurbinectedin in small-cell lung cancer.
Schultz CW, Zhang Y, Elmeskini R, Zimmermann A, Fu H, Murai Y, Wangsa D, Kumar S, Takahashi N, Atkinson D, Saha LK, Lee CF, Elenbaas B, Desai P, Sebastian R, Sharma AK, Abel M, Schroeder B, Krishnamurthy M, Bassel LL, Kumar R, Roper N, Aladjem M, Zenke FT, Ohler ZW, Pommier Y, Thomas A.
Schultz CW, et al. Among authors: thomas a.
EMBO Mol Med. 2024 Mar;16(3):664. doi: 10.1038/s44321-024-00029-x.
EMBO Mol Med. 2024.
PMID: 38366163
Free PMC article.